Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Results 1 - 3 of 3

Recs

0
Member Avatar pchop12316 (46.49) Submitted: 3/2/2015 10:41:08 AM : Underperform Start Price: $3.35 ROSG Score: +1.42

anything BUT optomistic at this point

Recs

0
Member Avatar 2gud2btrue (60.87) Submitted: 5/1/2014 10:28:02 AM : Outperform Start Price: $3.81 ROSG Score: -25.31

Target $10

Recs

0
Member Avatar KimLanners (< 20) Submitted: 11/16/2012 10:25:50 AM : Underperform Start Price: $3.69 ROSG Score: +15.51

I think this biotech is over and over!

Results 1 - 3 of 3

Featured Broker Partners


Advertisement